Achieve Life Sciences, Inc.
Price Action
Technical Summary
EMERGING TRENDAchieve Life Sciences, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 89), indicating clear outperformance against the broad market. Earnings growth of 49% provides fundamental context to the price action. However, price is extended 21% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $5.36 | +12.24% | ABOVE |
| 50 SMA | $4.99 | +20.75% | ABOVE |
| 100 SMA | $4.45 | +35.20% | ABOVE |
| 150 SMA | $4.56 | +31.90% | ABOVE |
| 200 SMA | $4.39 | +37.08% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is ACHV in an uptrend right now?
ACHV has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.
Is ACHV overbought or oversold?
ACHV's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.
Is ACHV outperforming the market?
ACHV has a Relative Strength (RS) Rating of 89 out of 99. Yes, ACHV is a market leader, outperforming 89% of all stocks over the past 12 months.
Where is ACHV in its 52-week range?
ACHV is trading at $6.02, which is 98% of its 52-week high ($6.16) and 97% above its 52-week low ($2.02).
How volatile is ACHV?
ACHV has a Beta of 1.87 and 52-week volatility of 100%. It's more volatile than the S&P 500 - expect bigger swings.